Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays

The companies said they will offer a "robust and streamlined workflow" that minimizes the number of manual steps required for targeted sequencing applications.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.